Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)

BATS BZX Real-Time Price
As of 11:34am ET
 +0.0079 / +2.77%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 2.25, with a high estimate of 2.50 and a low estimate of 2.00. The median estimate represents a +667.92% increase from the last price of 0.29.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.54%
Growthannually 54.50%


Growthquarterly -47.55%
Growthannually -26.01%
Key to the earnings and sales forecast charts.